High Throughput Screening (HTS) by EARO@EDDC
Screen up to 16,000 Compounds per Day per Project
The High Throughput Screening (HTS) platform specializes in small-molecule drug discovery projects and can help you to identify hits or tool compounds for your target/cell of interest. Several compound libraries are available (from small focus sets to large diverse collection of more than 300,000 curated compounds) to better cater your needs. Boasting a state-of-the-art and the only fully integrated automation platform in Singapore, the HTS platform can screen up to 16,000 compounds per day per project.
Scope of Services
Key Assay Expertise
To learn more about EARO, please visit www.earo.sg.
The HTS Platform is part of the EARO initiative, whose mission is to accelerate early-stage drug discovery in Singapore by providing access to EDDC’s expertise in Drug Discovery & Development and its industry-leading technologies.